<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37041034</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1976-9148</ISSN><JournalIssue CitedMedium="Print"><Volume>31</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Biomolecules &amp; therapeutics</Title><ISOAbbreviation>Biomol Ther (Seoul)</ISOAbbreviation></Journal><ArticleTitle>A Bivalent Inactivated Vaccine Prevents Enterovirus 71 and Coxsackievirus A16 Infections in the Mongolian Gerbil.</ArticleTitle><Pagination><StartPage>350</StartPage><EndPage>358</EndPage><MedlinePgn>350-358</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4062/biomolther.2023.058</ELocationID><Abstract><AbstractText>Hand-foot-and-mouth disease (HFMD) is a viral infectious disease that occurs in children under 5 years of age. Its main causes are coxsackievirus (CV) and enterovirus (EV). Since there are no efficient therapeutics for HFMD, vaccines are effective in preventing the disease. To develop broad coverage against CV and EV, the development of a bivalent vaccine form is needed. The Mongolian gerbil is an efficient and suitable animal model of EV71 C4a and CVA16 infection used to investigate vaccine efficacy following direct immunization. In this study, Mongolian gerbils were immunized with a bivalent inactivated EV71 C4a and inactivated CVA16 vaccine to test their effectiveness against viral infection. Bivalent vaccine immunization resulted in increased Ag-specific IgG antibody production; specifically, EV71 C4a-specific IgG was increased with medium and high doses and CVA16-specific IgG was increased with all doses of immunization. When gene expression of T cell-biased cytokines was analysed, Th1, Th2, and Th17 responses were found to be highly activated in the high-dose immunization group. Moreover, bivalent vaccine immunization mitigated paralytic signs and increased the survival rate following lethal viral challenges. When the viral RNA content was determined from various organs, all three doses of bivalent vaccine immunization were found to significantly decrease viral amplification. Upon histologic examination, EV71 C4a and CVA16 induced tissue damage to the heart and muscle. However, bivalent vaccine immunization alleviated this in a dose-dependent manner. These results suggest that the bivalent inactivated EV71 C4a/CVA16 vaccine could be a safe and effective candidate HFMD vaccine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Eun-Je</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, College of Pharmacy, and Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Suwon 16499, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Young-In</ForeName><Initials>YI</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, College of Pharmacy, and Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Suwon 16499, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seung-Yeon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Graduate School of Ajou University, Suwon 16499, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Sung Hyun</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>HK inno.N BIO Research Institute, BIO-Pharmaceutical Research Center, Icheon 17389, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hyoung Jin</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>HK inno.N BIO Research Institute, BIO-Pharmaceutical Research Center, Icheon 17389, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suh</LastName><ForeName>Bohyun</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>HK inno.N BIO Research Institute, BIO-Pharmaceutical Research Center, Icheon 17389, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jaelim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>HK inno.N BIO Research Institute, BIO-Pharmaceutical Research Center, Icheon 17389, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jeehye</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>HK inno.N BIO Research Institute, BIO-Pharmaceutical Research Center, Icheon 17389, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yoon Jung</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>HK inno.N BIO Research Institute, BIO-Pharmaceutical Research Center, Icheon 17389, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Eunju</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>HK inno.N BIO Research Institute, BIO-Pharmaceutical Research Center, Icheon 17389, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Sun-Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, College of Pharmacy, and Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Suwon 16499, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Biomol Ther (Seoul)</MedlineTA><NlmUniqueID>101472832</NlmUniqueID><ISSNLinking>1976-9148</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bivalent vaccine</Keyword><Keyword MajorTopicYN="N">Coxsackievirus A16</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Gerbil</Keyword><Keyword MajorTopicYN="N">Hand-foot-and-mouth disease</Keyword></KeywordList><CoiStatement>
<b>CONFLICT OF INTEREST</b>
. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>21</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37041034</ArticleId><ArticleId IdType="pmc">PMC10129857</ArticleId><ArticleId IdType="doi">10.4062/biomolther.2023.058</ArticleId><ArticleId IdType="pii">biomolther.2023.058</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arita M., Shimizu H., Nagata N., Ami Y., Suzaki Y., Sata T., Iwasaki, Miyamura T. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J. Gen. Virol. 2005;86:1391–1401. doi: 10.1099/vir.0.80784-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80784-0</ArticleId><ArticleId IdType="pubmed">15831951</ArticleId></ArticleIdList></Reference><Reference><Citation>Aswathyraj S., Arunkumar G., Alidjinou E. K., Hober D. Hand, foot and mouth disease (HFMD, emerging epidemiology and the need for a vaccine strategy. Med. Microbiol. Immunol. 2016;205:397–407. doi: 10.1007/s00430-016-0465-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-016-0465-y</ArticleId><ArticleId IdType="pubmed">27406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek S., Park S., Park H. K., Chun B. C. The epidemiological characteristics and spatio-temporal analysis of childhood hand, foot and mouth disease in Korea, 2011-2017. PLoS One. 2020;15:e0227803. doi: 10.1371/journal.pone.0227803.c7f68583881044cd9a5d1050b2d35a94</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0227803</ArticleId><ArticleId IdType="pmc">PMC6957343</ArticleId><ArticleId IdType="pubmed">31931518</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine E. A., Fuchs J., Das S. C., Partidos C. D., Osorio J. E. Efficacy of a trivalent hand, foot, and mouth disease vaccine against enterovirus 71 and coxsackieviruses A16 and A6 in mice. Viruses. 2015;7:5919–5932. doi: 10.3390/v7112916.0b99a08faabd449299e09b278d80096e</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7112916</ArticleId><ArticleId IdType="pmc">PMC4664989</ArticleId><ArticleId IdType="pubmed">26593938</ArticleId></ArticleIdList></Reference><Reference><Citation>Coates S. J., Davis M. D. P., Andersen L. K. Temperature and humidity affect the incidence of hand, foot, and mouth disease: a systematic review of the literature - a report from the International Society of Dermatology Climate Change Committee. Int. J. Dermatol. 2019;58:388–399. doi: 10.1111/ijd.14188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijd.14188</ArticleId><ArticleId IdType="pubmed">30187452</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan S., Liao Y., Jiang G., Jiang L., Wang L., Xu X., Feng M., Yang E., Zhang Y., Cui W., Li Q. Study of integrated protective immunity induced in rhesus macaques by the intradermal administration of a bivalent EV71-CA16 inactivated vaccine. Vaccine. 2020;38:2034–2044. doi: 10.1016/j.vaccine.2019.12.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.12.057</ArticleId><ArticleId IdType="pubmed">31982260</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K., Nagata N., Sato Y., Ong K. C., Wong K. T., Yamayoshi S., Shimanuki M., Shitara H., Taya C., Koike S. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc. Natl. Acad. Sci. U. S. A. 2013;110:14753–14758. doi: 10.1073/pnas.1217563110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217563110</ArticleId><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="pubmed">23959904</ArticleId></ArticleIdList></Reference><Reference><Citation>Goksugur N., Goksugur S. Images in clinical medicine. Hand, foot, and mouth disease. N. Engl. J. Med. 2010;362:e49. doi: 10.1056/NEJMicm0910628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMicm0910628</ArticleId><ArticleId IdType="pubmed">20375401</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan X., Che Y., Wei S., Li S., Zhao Z., Tong Y., Wang L., Gong W., Zhang Y., Zhao Y., Wu Y., Wang S., Jiang R., Huang J., Liu Y., Luo W., Liao Y., Hu X., Zhang W., Dai Y., Jiang G., Min G., Liu F., You X., Xu X., Li J., Li C., Fan S., Hang L., Huang Q., Li Q. Effectiveness and safety of an inactivated enterovirus 71 vaccine in children aged 6-71 months in a phase IV study. Clin. Infect. Dis. 2020;71:2421–2427. doi: 10.1093/cid/ciz1114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciz1114</ArticleId><ArticleId IdType="pubmed">31734699</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Y., He Z. J., Tao W., Fu T., Wang Y. K., Chen Y. Experimental infection of Z:ZCLA Mongolian gerbils with human hepatitis E virus. World J. Gastroenterol. 2015;21:862–867. doi: 10.3748/wjg.v21.i3.862.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v21.i3.862</ArticleId><ArticleId IdType="pmc">PMC4299338</ArticleId><ArticleId IdType="pubmed">25624719</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong W. X., Yan B., Yeo H., Tan E. L., Lee J. J., Ng J. K. W., Chow V. T., Alonso S. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J. Virol. 2012;86:2121–2131. doi: 10.1128/JVI.06103-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06103-11</ArticleId><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Koike S. Cellular receptors for enterovirus A71. J. Biomed. Sci. 2020;27:23. doi: 10.1186/s12929-020-0615-9.99dc42bf142b433398641c9bcf6f9c9d</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugraheni K., Saputri F. C. The effect of secang extract (Caesalpinia sappan linn) on the weight and histology appearance of white male rats' hearts induced by isoproterenol. Int. J. Appl. Pharm. 2017;9:59–61. doi: 10.22159/ijap.2017.v9s1.35_41.</Citation><ArticleIdList><ArticleId IdType="doi">10.22159/ijap.2017.v9s1.35_41</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z., Liu Q., Ye X., Cai Y., Wang X., Shi J., Li D., Jin X., An W., Huang Z. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. Vaccine. 2014;32:4296–4303. doi: 10.1016/j.vaccine.2014.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.06.025</ArticleId><ArticleId IdType="pubmed">24950363</ArticleId></ArticleIdList></Reference><Reference><Citation>Legay F., Leveque N., Gacouin A., Tattevin P., Bouet J., Thomas R., Chomelt J. J. Fatal coxsackievirus A-16 pneumonitis in adult. Emerg. Infect. Dis. 2007;13:1084–1086. doi: 10.3201/eid1307.070295.c14f541af95f47098cf90dcf9262fa70</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1307.070295</ArticleId><ArticleId IdType="pmc">PMC2878248</ArticleId><ArticleId IdType="pubmed">18214187</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Zhu R., Qian Y., Deng J., Sun Y., Liu L., Wang F., Zhao L. Comparing Enterovirus 71 with Coxsackievirus A16 by analyzing nucleotide sequences and antigenicity of recombinant proteins of VP1s and VP4s. BMC Microbiol. 2011;11:246. doi: 10.1186/1471-2180-11-246.284da4930c3343e4879f2cb163543206</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-11-246</ArticleId><ArticleId IdType="pmc">PMC3217892</ArticleId><ArticleId IdType="pubmed">22050722</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Leung K., Jit M., Yu H., Yang J., Liao Q., Liu F., Zheng Y., Wu J. T. Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease. Clin. Microbiol. Infect. 2020;26:373–380. doi: 10.1016/j.cmi.2019.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2019.06.029</ArticleId><ArticleId IdType="pmc">PMC6942242</ArticleId><ArticleId IdType="pubmed">31279839</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Mo Z., Liang Z., Zhang Y., Li R., Ong K. C., Wong K. T., Yang E., Che Y., Wang J., Dong C., Feng M., Pu J., Wang L., Liao Y., Jiang L., Tan S. H., David P., Huang T., Zhou Z., Wang X., Xia J., Guo L., Wang L., Xie Z., Cui W., Mao Q., Liang Y., Zhao H., Na R., Cui P., Shi H., Wang J., Li Q. Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations. BMC Med. 2015;13:226. doi: 10.1186/s12916-015-0448-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-015-0448-7</ArticleId><ArticleId IdType="pmc">PMC4574357</ArticleId><ArticleId IdType="pubmed">26381232</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Zhao H., Zhang Y., Wang J., Che Y., Dong C., Zhang X., Na R., Shi H., Jiang L., Wang L., Xie Z., Cui P., Xiong X., Liao Y., Zhao S., Gao J., Tang D., Li Q. Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection. Virology. 2011;412:91–100. doi: 10.1016/j.virol.2010.12.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.12.058</ArticleId><ArticleId IdType="pubmed">21262515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokugamage N., Kariwa H., Lokugamage K., Hagiya T., Miyamoto H., Iwasa M. A., Araki K., Yoshimatsu K., Arikawa J., Mizutani T., Takashima I. Development of an efficient method for recovery of Puumala and Puumala-related viruses by inoculation of Mongolian gerbils. J. Vet. Med. Sci. 2003;65:1189–1194. doi: 10.1292/jvms.65.1189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1292/jvms.65.1189</ArticleId><ArticleId IdType="pubmed">14665747</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuzaki H., Doi K., Mitsuoka T., Tsuda T., Onodera T. Experimental encephalomyocarditis virus infection in Mongolian gerbils (Meriones unguiculatus) Vet. Pathol. 1989;26:11–17. doi: 10.1177/030098588902600103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/030098588902600103</ArticleId><ArticleId IdType="pubmed">2536510</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng T., Kwang J. Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice. J. Virol. 2014;88:5803–5815. doi: 10.1128/JVI.00289-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00289-14</ArticleId><ArticleId IdType="pmc">PMC4019108</ArticleId><ArticleId IdType="pubmed">24623423</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura Y., Nakaya T., Hagiwara K., Momiyama N., Kagawa Y., Taniyama H., Ishihara C., Sata T., Kurata T., Ikuta K. High susceptibility of Mongolian gerbil (Meriones unguiculatus) to Borna disease virus. Vaccine. 1999;17:480–489. doi: 10.1016/S0264-410X(98)00222-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(98)00222-9</ArticleId><ArticleId IdType="pubmed">10073727</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogi M., Yano Y., Chikahira M., Takai D., Oshibe T., Arashiro T., Hanaoka N., Fujimoto T., Hayashi Y. Characterization of genome sequences and clinical features of coxsackievirus A6 strains collected in Hyogo, Japan in 1999-2013. J. Med. Virol. 2017;89:1395–1403. doi: 10.1002/jmv.24798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24798</ArticleId><ArticleId IdType="pubmed">28229467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi M. H., Wong S. C., Lewthwaite P., Cardosa M. J., Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097–1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Osorio J. E., Schoepp R. J., Yuill T. M. Effects of La Crosse virus infection on pregnant domestic rabbits and mongolian gerbils. Am. J. Trop. Med. Hyg. 1996;55:384–390. doi: 10.4269/ajtmh.1996.55.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1996.55.384</ArticleId><ArticleId IdType="pubmed">8916793</ArticleId></ArticleIdList></Reference><Reference><Citation>Porres C. P., Grothe B., Felmy F. Breakdown of excitability by attenuated PRV-152 infection in auditory brainstem neurons of Mongolian gerbils. Neuroscience. 2017;367:1–9. doi: 10.1016/j.neuroscience.2017.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2017.10.020</ArticleId><ArticleId IdType="pubmed">29069619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J., Wang X., Zhu L., Hu Z., Gao Q., Yang P., Li X., Wang J., Shen X., Fry E. E., Rao Z., Stuart D. I. Structures of coxsackievirus A16 capsids with native antigenicity: implications for particle expansion, receptor binding, and immunogenicity. J. Virol. 2015;89:10500–10511. doi: 10.1128/JVI.01102-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01102-15</ArticleId><ArticleId IdType="pmc">PMC4580203</ArticleId><ArticleId IdType="pubmed">26269176</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar P. K., Sarkar N. K., Tayab M. A. Hand, foot and mouth disease (HFMD): an update. Bangladesh J. Child Heath. 2016;40:115–119. doi: 10.3329/bjch.v40i2.31567.</Citation><ArticleIdList><ArticleId IdType="doi">10.3329/bjch.v40i2.31567</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y. S., Li Y. J., Xia Y., Xu F., Wang W. W., Yang Z. N., Lu H. J., Chen Z. P., Miao Z. P., Liang W. F., Xu Z. Y., Dong H. J., Qiu D. H., Zhu Z. Y., Van Der Veen S., Qian J., Zhou B., Yao P. P., Zhu H. P. Coxsackievirus A16 induced neurological disorders in young gerbils which could serve as a new animal model for vaccine evaluation. Sci. Rep. 2016;6:34299. doi: 10.1038/srep34299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep34299</ArticleId><ArticleId IdType="pmc">PMC5035925</ArticleId><ArticleId IdType="pubmed">27667023</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y. S., Xia Y., Xu F., Lu H. J., Mao Z. A., Gao M., Pan T. Y., Yao P. P., Wang Z., Zhu H. P. Development and evaluation of an inactivated coxsackievirus A16 vaccine in gerbils. Emerg. Microbes Infect. 2022;11:1994–2006. doi: 10.1080/22221751.2022.2093132.f52fee290cf8497b8bad85f017d1b549</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2093132</ArticleId><ArticleId IdType="pmc">PMC9377242</ArticleId><ArticleId IdType="pubmed">35787233</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C. Y., Li Lu F., Wu M. H., Lee C. Y., Huang L. M. Fatal coxsackievirus A16 infection. Pediatr. Infect. Dis. J. 2004;23:275–276. doi: 10.1097/01.inf.0000115950.63906.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000115950.63906.78</ArticleId><ArticleId IdType="pubmed">15014311</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F., Yao P. P., Xia Y., Qian L., Yang Z. N., Xie R. H., Sun Y. S., Lu H. J., Miao Z. P., Li C., Li X., Liang W. F., Huang X. X., Xia S. C., Chen Z. P., Jiang J. M., Zhang Y. J., Mei L. L., Liu S. L., Gu H., Xu Z. Y., Fu X. F., Zhu Z. Y., Zhu H. P. Enterovirus 71 infection causes severe pulmonary lesions in gerbils, meriones unguiculatus, which can be prevented by passive immunization with specific antisera. PLoS One. 2015;10:e0119173. doi: 10.1371/journal.pone.0119173.cfa1d27c31a74f03b151ccce5a7038ef</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0119173</ArticleId><ArticleId IdType="pmc">PMC4359154</ArticleId><ArticleId IdType="pubmed">25767882</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T., Xie T., Song X., Shen D., Li H., Yue L., Jiang Q., Zhu F., Meng H., Long R., Yang R., Luo F., Xie Z. Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys. Hum. Vaccin. Immunother. 2020;16:1586–1594. doi: 10.1080/21645515.2019.1709353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2019.1709353</ArticleId><ArticleId IdType="pmc">PMC7482759</ArticleId><ArticleId IdType="pubmed">32159429</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao P. P., Qian L., Xia Y., Xu F., Yang Z. N., Xie R. H., Li X., Liang W. F., Huang X. X., Zhu Z. Y., Zhu H. P. Enterovirus 71-induced neurological disorders in young gerbils, Meriones unguiculatus: development and application of a neurological disease model. PLoS One. 2012;7:e51996. doi: 10.1371/journal.pone.0051996.a47c6b85357e4d50ae9c7f49df44758f</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0051996</ArticleId><ArticleId IdType="pmc">PMC3528719</ArticleId><ArticleId IdType="pubmed">23284845</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi E. J., Shin Y. J., Kim J. H., Kim T. G., Chang S. Y. Enterovirus 71 infection and vaccines. Clin. Exp. Vaccine Res. 2017;6:4–14. doi: 10.7774/cevr.2017.6.1.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2017.6.1.4</ArticleId><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L., He J., Wang L., Yi H. Incidence, aetiology, and serotype spectrum analysis of adult hand, foot, and mouth disease patients: a retrospective observational cohort study in northern Zhejiang, China. Int. J. Infect. Dis. 2019;85:28–36. doi: 10.1016/j.ijid.2019.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2019.05.016</ArticleId><ArticleId IdType="pubmed">31100417</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Dai W., Zhang C., Zhou Y., Xiong P., Wang S., Ye X., Liu Q., Zhou D., Huang Z. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity. Emerg. Microbes Infect. 2018;7:94. doi: 10.1038/s41426-018-0094-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41426-018-0094-1</ArticleId><ArticleId IdType="pmc">PMC5959873</ArticleId><ArticleId IdType="pubmed">29777102</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Cui W., Liu L., Wang J., Zhao H., Liao Y., Na R., Dong C., Wang L., Xie Z., Gao J., Cui P., Zhang X., Li Q. Pathogenesis study of enterovirus 71 infection in rhesus monkeys. Lab. Invest. 2011;91:1337–1350. doi: 10.1038/labinvest.2011.82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2011.82</ArticleId><ArticleId IdType="pubmed">21555996</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F. C., Meng F. Y., Li J. X., Li X. L., Mao Q. Y., Tao H., Zhang Y. T., Yao X., Chu K., Chen Q. H., Hu Y. M., Wu X., Liu P., Zhu L. Y., Gao F., Jin H., Chen Y. J., Dong Y. Y., Liang Y. C., Shi N. M., Ge H. M., Liu L., Chen S. G., Ai X., Zhang Z. Y., Ji Y. G., Luo F. J., Chen X. Q., Zhang Y., Zhu L. W., Liang Z. L., Shen X. L. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381:2024–2032. doi: 10.1016/S0140-6736(13)61049-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61049-1</ArticleId><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorio D. A. R., Monsma S., Sanes D. H., Golding N. L., Rubel E. W., Wang Y. De novo sequencing and initial annotation of the Mongolian gerbil (Meriones unguiculatus) genome. Genomics. 2019;111:441–449. doi: 10.1016/j.ygeno.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2018.03.001</ArticleId><ArticleId IdType="pmc">PMC6129228</ArticleId><ArticleId IdType="pubmed">29526484</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>